MassIVE MSV000081061

Partial Public

De Novo Proteome in Fragile X Syndrome

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

Elevated translation has been reported in multiple models of fragile X syndrome (FXS) and in FXS individuals, however, whether it is limited to fragile X mental retardation protein (FMRP) target mRNAs or neuronal activity-derived conditions remains unclear. We examined this question by measuring the de novo proteome of the Fmr1 knockout (KO) mouse hippocampus compared to normal littermates in steady-state and mGluR-stimulated conditions. Our results reveal that the altered de novo translational profile in KO mice involves similar numbers of upregulated and downregulated proteins in both conditions and that mGluR-dependent translation in KOs is variable and inconsistent compared to normal. Nascent proteins from the steady-state translation and activity-dependent translation groups had little overlap and the mRNAs of the candidate proteins did not possess any unifying motifs or properties. Validation of the highest interest FXS candidates revealed differences in de novo synthesis and final abundance levels, which correlated with changes in synaptic levels of miRNA. Taken together, these data suggest that translation is stimulus-specific and not generalized, and that there is more complex, multi-tiered regulation of protein expression that is disrupted in FXS than previously described. To establish relevance of these data to human patients and future biomarker efforts, three candidates were examined in FXS patient plasma and two exhibited altered expression. One was rescued in KO mice blood following a treatment shown previously to ameliorate phenotypes in FXS model mice. In summary, our results provide a clear distinction between steady-state and activity-dependent de novo proteomic profiles in FXS model mice, providing a database of proteins that are synthesized incorrectly, and describe a novel approach for developing biomarkers for FXS. [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: SILAC ; BONCAT ; Fragile X Syndrome

Contact

Principal Investigators:
(in alphabetical order) 		Dr. Thomas A. Neubert, New York University School of Medicine, USA
Submitting User: neubertlab
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.